These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23559101)

  • 1. A pan-European comparison of the use of mineral trioxide aggregate (MTA) by postgraduates in paediatric dentistry.
    Foley JI
    Eur Arch Paediatr Dent; 2013 Apr; 14(2):113-6. PubMed ID: 23559101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of mineral trioxide aggregate (MTA by postgraduates in restorative dentistry in the UK.
    Foley JI
    Eur J Prosthodont Restor Dent; 2011 Dec; 19(4):179-83. PubMed ID: 22645805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dental Material Choices for Pulp Therapy in Paediatric Dentistry.
    Ha WN; Kahler B; Walsh LJ
    Eur Endod J; 2017; 2(1):1-6. PubMed ID: 33403336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview - part I: vital pulp therapy.
    Parirokh M; Torabinejad M; Dummer PMH
    Int Endod J; 2018 Feb; 51(2):177-205. PubMed ID: 28836288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological, ultrastructural and quantitative investigations on the response of healthy human pulps to experimental capping with mineral trioxide aggregate: a randomized controlled trial.
    Nair PN; Duncan HF; Pitt Ford TR; Luder HU
    Int Endod J; 2008 Feb; 41(2):128-50. PubMed ID: 17956562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineral trioxide aggregate material use in endodontic treatment: a review of the literature.
    Roberts HW; Toth JM; Berzins DW; Charlton DG
    Dent Mater; 2008 Feb; 24(2):149-64. PubMed ID: 17586038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study.
    Subramaniam P; Konde S; Mathew S; Sugnani S
    J Clin Pediatr Dent; 2009; 33(4):311-4. PubMed ID: 19725237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Courson F; Durieux P; Muller-Bolla M; Glenny AM; Fron Chabouis H
    Cochrane Database Syst Rev; 2014 Aug; (8):CD003220. PubMed ID: 25099759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth.
    Agamy HA; Bakry NS; Mounir MM; Avery DR
    Pediatr Dent; 2004; 26(4):302-9. PubMed ID: 15344622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey on the teaching and use of mineral trioxide aggregate in UK dental schools.
    Pitt Ford T; Mannocci F; Woolford M
    Eur J Dent Educ; 2007 Aug; 11(3):155-9. PubMed ID: 17640259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic evaluation of pulpotomies in dog using two types of mineral trioxide aggregate and regular and white Portland cements as wound dressings.
    Menezes R; Bramante CM; Letra A; Carvalho VG; Garcia RB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):376-9. PubMed ID: 15356480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current opinions and use of MTA for apical barrier formation of non-vital immature permanent incisors by consultants in paediatric dentistry in the UK.
    Mooney GC; North S
    Dent Traumatol; 2008 Feb; 24(1):65-9. PubMed ID: 18173669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scanning electron microscopy evaluation of the hard tissue barrier after pulp capping with calcium hydroxide, mineral trioxide aggregate (MTA) or ProRoot MTA.
    Reston EG; de Souza Costa CA
    Aust Endod J; 2009 Aug; 35(2):78-84. PubMed ID: 19703080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The teaching of management of the pulp in primary molars across Europe.
    Monteiro J; Ní Chaollaí A; Duggal M
    Eur Arch Paediatr Dent; 2017 Jun; 18(3):203-208. PubMed ID: 28493112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, radiographic and histological analysis of the effects of mineral trioxide aggregate used in direct pulp capping and pulpotomies of primary teeth.
    Caicedo R; Abbott PV; Alongi DJ; Alarcon MY
    Aust Dent J; 2006 Dec; 51(4):297-305. PubMed ID: 17256303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial.
    Sakai VT; Moretti AB; Oliveira TM; Fornetti AP; Santos CF; Machado MA; Abdo RC
    Br Dent J; 2009 Aug; 207(3):E5; discussion 128-9. PubMed ID: 19629145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTA pulpotomy as an alternative to root canal treatment in children's permanent teeth in a dental public health setting.
    Alqaderi HE; Al-Mutawa SA; Qudeimat MA
    J Dent; 2014 Nov; 42(11):1390-5. PubMed ID: 24973732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineral trioxide aggregate--a review.
    Rao A; Rao A; Shenoy R
    J Clin Pediatr Dent; 2009; 34(1):1-7. PubMed ID: 19953801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.
    Noorollahian H
    Br Dent J; 2008 Jun; 204(11):E20. PubMed ID: 18425074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTA applications in pediatric dentistry.
    Maturo P; Costacurta M; Bartolino M; Docimo R
    Oral Implantol (Rome); 2009 Jul; 2(3):37-44. PubMed ID: 23285367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.